The company's performance hints at unresolved challenges, worse than the annualised loss of 5% over the last half decade. Investors are advised to monitor the fundamentals for potential opportunities, ensuring they invest in a high quality business.

The company's financial state is worrying, with towering liabilities eclipsing cash and other receivables, coupled with dropping revenues and EBIT level loss. This heightened investment risk and if operations aren't swiftly improved, the stock might lose interest.

Underperformance may suggest unresolved issues for Sinochem. Potential for investment if recovery occurs. Investors are reminded to verify the quality of business before buying in a low market. Based on its poor performance, Sinochem may not be an ideal buy for now.